-transparent.png){kind=logo}
Serious infections by methicillin-resistant staphylococci, 26 caused by Staphylococcus aureus and two by coagulase-negative staphylococci, were treated with teicoplanin 200-800 mg daily, in eight cases supplemented with another antibiotic. The overall rate of clinical cure or improvement was 75%, and that of bacterial eradication 67%.
Related Publications
Y J Drabu, and
B Walsh, and
P H Blakemore, and
S Mehtar
January 2003,
Zhurnal mikrobiologii, epidemiologii i immunobiologii,
Y J Drabu, and
B Walsh, and
P H Blakemore, and
S Mehtar
January 1996,
The Journal of antimicrobial chemotherapy,
Y J Drabu, and
B Walsh, and
P H Blakemore, and
S Mehtar
September 1999,
The Journal of antimicrobial chemotherapy,
Y J Drabu, and
B Walsh, and
P H Blakemore, and
S Mehtar
September 2001,
Pathologie-biologie,
Y J Drabu, and
B Walsh, and
P H Blakemore, and
S Mehtar
November 1985,
Presse medicale (Paris, France : 1983),
Y J Drabu, and
B Walsh, and
P H Blakemore, and
S Mehtar
May 2020,
Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy,
Y J Drabu, and
B Walsh, and
P H Blakemore, and
S Mehtar
September 1997,
Revista clinica espanola,
Y J Drabu, and
B Walsh, and
P H Blakemore, and
S Mehtar
November 1992,
Enfermedades infecciosas y microbiologia clinica,
Y J Drabu, and
B Walsh, and
P H Blakemore, and
S Mehtar
January 1988,
The Journal of antimicrobial chemotherapy,
Y J Drabu, and
B Walsh, and
P H Blakemore, and
S Mehtar
January 2002,
Medicina,
